High-dose tumor necrosis factor-alpha leads to the systemic inflammatory response syndrome

American Journal of Medicine

Volumn 105, Issue 4, 1998, Pages 346-347

  Oldhafer, Karl J ^a   Lang, Hauke ^a   Kuse, Ernst R ^a   Martin, Michael U ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MELPHALAN; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER IMMUNOTHERAPY; CAPILLARY LEAK SYNDROME; CASE REPORT; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPOTENSION; INFLAMMATION; LIVER FAILURE; LIVER METASTASIS; LIVER NECROSIS; LIVER PERFUSION; LUNG FUNCTION; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGIONAL PERFUSION; SYNDROME;

EID: 0032192523     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00265-4     Document Type: Article

References (6)

1. 1. Dinarello CA, Gelfand JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA. 1993;269:1829-1835.
2. 2. Davies MG, Hagen P-O. Systemic inflammatory response syndrome. Br J Surg. 1997;84:920-935.
3. 3. Wang JH, Redmond HP, Watson RW, Bouchier-Hayes D. Role of lipopolysaccharide and tumor necrosis factor-alpha in induction of hepatocyte necrosis. Am J Physiol. 1995;269:297-304.
4. 4. Frei E, Spriggs D. Tumor necrosis factor: still a promising agent. J Clin Oncol 1989;7:291-294.
5. 5. Eggermont AMM, Koops HS, Klausner JM, et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. Ann Surg. 1996;224:756-765.
6. 6. Fraker DL, Alexander HR, Thorn AK. Use of tumor necrosis factor in isolated hepatic perfusion. Circ Shock. 1994;44:45-50.